2020
DOI: 10.4103/ijn.ijn_271_18
|View full text |Cite
|
Sign up to set email alerts
|

Amyloid goiter in a patient with rheumatoid arthritis and end-stage renal disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(3 citation statements)
references
References 12 publications
0
3
0
Order By: Relevance
“…The amyloid involvement can result from primarily localized deposition or secondary to systemic disease [ 4 ]. 50% to 80% of individuals with medullary carcinoma of the thyroid exhibit microscopic amyloid deposition, followed by secondary amyloidosis (20%) and very rarely primary amyloidosis (15%) [ 1 , 3 , 4 ]. Most patients with amyloid goiter are euthyroid, but variations have also been reported [ 1 ].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The amyloid involvement can result from primarily localized deposition or secondary to systemic disease [ 4 ]. 50% to 80% of individuals with medullary carcinoma of the thyroid exhibit microscopic amyloid deposition, followed by secondary amyloidosis (20%) and very rarely primary amyloidosis (15%) [ 1 , 3 , 4 ]. Most patients with amyloid goiter are euthyroid, but variations have also been reported [ 1 ].…”
Section: Discussionmentioning
confidence: 99%
“…In primary amyloidosis, there is the accumulation of major fibrillar protein amyloid L derived from IgE light chains. However, in secondary amyloidosis, there is a collection of amyloid A derived from serum amyloid A protein [ 3 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation